Skip to main content

International Journal of Clinical Oncology

Ausgabe 8/2021

Including Invited Reviews on Liquid biopsy

Inhalt (19 Artikel)

Open Access Special Article

Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2020 for the Clinical Practice of Hereditary Colorectal Cancer

Naohiro Tomita, Hideyuki Ishida, Kohji Tanakaya, Tatsuro Yamaguchi, Kensuke Kumamoto, Toshiaki Tanaka, Takao Hinoi, Yasuyuki Miyakura, Hirotoshi Hasegawa, Tetsuji Takayama, Hideki Ishikawa, Takeshi Nakajima, Akiko Chino, Hideki Shimodaira, Akira Hirasawa, Yoshiko Nakayama, Shigeki Sekine, Kazuo Tamura, Kiwamu Akagi, Yuko Kawasaki, Hirotoshi Kobayashi, Masami Arai, Michio Itabashi, Yojiro Hashiguchi, Kenichi Sugihara, Naohiro Tomita, Hideyuki Ishida, Koji Tanakaya, Tatsuro Yamaguchi, Kensuke Kumamoto, Toshiaki Tanaka, Takao Hinoi, Yasuyuki Miyakura, Hirotoshi Hasegawa, Hideki Ishikawa, Takeshi Nakajima, Akiko Chino, Shigeki Sekine, Kazuo Tamura, Kiwamu Akagi, Hirotoshi Kobayashi, Masami Arai, Michio Itabashi, Yojiro Hashiguchi, Kenichi Sugihara

Invited Review Article

Perspectives for circulating tumor DNA in clinical management of colorectal cancer

Ichiro Takemasa, Atsushi Hamabe, Masayuki Ishii

Open Access Original Article

Current trend in treatment of glioblastoma in Japan: a national survey using the diagnostic procedure combination database (J-ASPECT study-glioblastoma)

Yusuke Funakoshi, Nobuhiro Hata, Daisuke Kuga, Ryusuke Hatae, Yuhei Sangatsuda, Yutaka Fujioka, Kosuke Takigawa, Koji Yoshimoto, Masahiro Mizoguchi, Koji Iihara

Original Article

Sarcopenia is related to poor prognosis in patients after trimodality therapy for locally advanced non-small cell lung cancer

Kuniaki Katsui, Takeshi Ogata, Kenta Watanabe, Kotaro Yoshio, Masahiro Kuroda, Masaomi Yamane, Takao Hiraki, Katsuyuki Kiura, Shinichi Toyooka, Susumu Kanazawa

Original Article

Long-term results of fluorescence and indigo carmine blue dye-navigated sentinel lymph node biopsy

Sota Asaga, Ai Tsuchiya, Yoshiharu Ishizaka, Kaisuke Miyamoto, Hiroki Ito, Hirotsugu Isaka, Tomohiro Chiba, Shigeru Imoto, Hiroshi Kamma

Original Article

Polymorphism of TUSC7 associated with gastric cancer susceptibility and binding with miR-133a-3p: a population-based case–control study

Qian Yang, Chunhua Song, Peng Wang, Hua Ye, Liping Dai, Jianying Zhang, Kaijuan Wang

Original Article

Risk factors of mFOLFOX6-induced hyperammonemia in patients with colorectal cancer: an observational study

Kazuaki Okamoto, Hiroaki Nozawa, Kumiko Hongo, Yuuki Iida, Kazushige Kawai, Kazuhito Sasaki, Koji Murono, Yusuke Kita, Yukio Ishihara, Naoki Takabayashi, Ryo Kobayashi, Takeyuki Hiramatsu, Soichiro Ishihara

Original Article

Cost-effectiveness of self-expandable metallic stents as bridge to surgery for obstructive colorectal cancer

Takayoshi Kaida, Koichi Doi, Shinsei Yumoto, Shotaro Kinoshita, Hideaki Takeyama, Hiroyuki Ishiodori, Hideo Baba

Original Article

Negative prognostic outcomes of percutaneous transhepatic biliary drainage in distal cholangiocarcinoma: a retrospective analysis using propensity score matching

Yutaro Matsunaga, Ryota Higuchi, Takehisa Yazawa, Shuichiro Uemura, Wataru Izumo, Takehiro Ota, Toru Furukawa, Masakazu Yamamoto

Original Article

On-treatment C-reactive protein control could predict response to subsequent anti-PD-1 treatment in metastatic renal cell carcinoma

Kimiharu Takamatsu, Ryuichi Mizuno, Yuto Baba, Yota Yasumizu, Nobuyuki Tanaka, Suguru Shirotake, Toshikazu Takeda, Shinya Morita, Kazuhiro Matsumoto, Takeo Kosaka, Hiroshi Asanuma, Masafumi Oyama, Shuji Mikami, Mototsugu Oya

Original Article

Prognostic factors in patients with metastatic urothelial carcinoma who have treated with Atezolizumab

Deniz Tural, Ömer Fatih Ölmez, Ahmet Taner Sümbül, Nail Özhan, Burcu Çakar, Osman Köstek, Meltem Ekenel, Mustafa Erman, Hasan Şenol Coşkun, Fatih Selçukbiricik, Özge Keskin, Fatma Paksoy Türköz, Kerem Oruç, Selami Bayram, İrem Bilgetekin, Birol Yıldız, Mehmet Ali Nahit Şendur, Nail Paksoy, Ahmet Dirican, Dilek Erdem, Meltem Selam, Özgür Tanrıverdi, Semra Paydaş, Zuhat Urakçı, Elif Atağ, Sabri Güncan, Yüksel Ürün, Ali Alkan, Ali Osman Kaya, Deniz Tataroğlu Özyükseler, Halil Taşkaynatan, Mustafa Yıldırım, Müge Sönmez, Tuğba Başoğlu, Şeyda Gündüz, Saadettin Kılıçkap, Mehmet Artaç

Original Article

Intra-corporeal robot-assisted versus open radical cystectomy: a propensity score-matched analysis comparing perioperative and long-term survival outcomes and recurrence patterns

Kenji Zennami, Makoto Sumitomo, Kiyoshi Takahara, Takuhisa Nukaya, Masashi Takenaka, Kosuke Fukaya, Manabu Ichino, Naohiko Fukami, Hitomi Sasaki, Mamoru Kusaka, Ryoichi Shiroki

Original Article

Identification of Lynch syndrome-associated DNA mismatch repair-deficient bladder cancer in a Japanese hospital-based population

Makoto Kagawa, Satoru Kawakami, Azusa Yamamoto, Okihide Suzuki, Nao Kamae, Hidetaka Eguchi, Yasushi Okazaki, Gou Yamamoto, Kiwamu Akagi, Jun-ichi Tamaru, Tatsuro Yamaguchi, Tomio Arai, Hideyuki Ishida

Original Article

Prognostic impact of bone metastatic volume beyond vertebrae and pelvis in patients with metastatic hormone-sensitive prostate cancer

Kotaro Suzuki, Yasuyoshi Okamura, Takuto Hara, Tomoaki Terakawa, Junya Furukawa, Kenichi Harada, Nobuyuki Hinata, Masato Fujisawa

Original Article

Clinico-pathological characteristics of patients with stage IB1–IB2 (FIGO 2018) uterine cervical cancer: a nationwide study in Japan

Keita Tsuji, Muneaki Shimada, Fumiaki Takahashi, Hideki Tokunaga, Imari Deura, Satoshi Yamaguchi, Toru Nakanishi, Koji Matsuo, Nobuo Yaegashi, Mikio Mikami

Open Access Original Article

4-step, 2-h carboplatin desensitization in Japanese patients with ovarian cancer: a prospective study

Meiko Nishimura, Hideki Sakai, Takuma Onoe, Shogen Boku, Takaaki Yokoyama, Genmu Kadokura, Satoshi Morita, Noriyuki Katsumata, Koji Matsumoto

Original Article

Correlation between oncological family history and clinical outcome in a large monocentric cohort of pediatric patients with rhabdomyosarcoma

Valentina Sottili, Stefano Signoroni, Francesco Barretta, Jacopo Azzollini, Siranoush Manoukian, Roberto Luksch, Monica Terenziani, Michela Casanova, Filippo Spreafico, Cristina Meazza, Marta Podda, Veronica Biassoni, Elisabetta Schiavello, Stefano Chiaravalli, Maura Massimino, Patrizia Gasparini, Andrea Ferrari

Zur Zeit gratis COVID-19 Original Article

Delayed diagnosis and treatment of children with cancer during the COVID-19 pandemic

Michal Dvori, Sarah Elitzur, Assaf Barg, Shlomit Barzilai-Birenboim, Gil Gilad, Shirah Amar, Helen Toledano, Amos Toren, Sigal Weinreb, Gal Goldstein, Adi Shapira, Shifra Ash, Shai Izraeli, Oded Gilad

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Perioperative Checkpointhemmer-Therapie verbessert NSCLC-Prognose

28.05.2024 NSCLC Nachrichten

Eine perioperative Therapie mit Nivolumab reduziert das Risiko für Rezidive und Todesfälle bei operablem NSCLC im Vergleich zu einer alleinigen neoadjuvanten Chemotherapie um über 40%. Darauf deuten die Resultate der Phase-3-Studie CheckMate 77T.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.